## **Core Concept**
The core concept being tested here is the prevention of tuberculosis (TB) through chemoprophylaxis. The goal is to identify the most appropriate drug used for preventing the progression from latent TB infection to active TB disease.

## **Why the Correct Answer is Right**
Isoniazid (INH) is the correct answer because it is the first-line drug recommended for the prophylaxis of tuberculosis. INH works by inhibiting the synthesis of mycolic acid, a critical component of the Mycobacterium tuberculosis cell wall. It is effective in preventing the progression from latent TB infection to active disease, especially in high-risk populations such as those with recent exposure to TB, HIV-infected individuals, and those with certain medical conditions.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Rifampicin is a key drug in the treatment of active TB but is not the first choice for prophylaxis due to its potential for resistance development when used alone.
- **Option B:** Ethambutol is another drug used in the treatment of TB but not typically used for prophylaxis due to its potential for optic neuritis and the availability of more effective options for prevention.
- **Option C:** Pyrazinamide is used in combination with other drugs for the treatment of active TB but is not the preferred agent for prophylaxis.

## **Clinical Pearl / High-Yield Fact**
A crucial point to remember is that Isoniazid (INH) is the drug of choice for TB prophylaxis, and its use is recommended for 6-9 months in most guidelines. It's also important to note that INH can cause hepatotoxicity and peripheral neuropathy, and monitoring of liver function tests is advised during its use.

## **Correct Answer:** . Isoniazid